Even Capital has invested in New Zealand-based Daisy Lab, a precision fermentation start-up, to accelerate its innovative approach to sustainable protein production.
Information on the Target
Daisy Lab is an innovative precision fermentation start-up based in New Zealand, recognized for its pioneering efforts in the food technology sector. Founded by a trio of accomplished female entrepreneurs, Daisy Lab is focused on creating sustainable solutions to address significant global issues such as climate change and food insecurity.
The company leverages advanced microbial technology to produce high-quality proteins and various biomolecules. This approach not only aims to fulfill growing protein demands but also seeks to minimize greenhouse gas emissions and reduce the consumption of land and water resources, presenting a more humane alternative to traditional animal farming.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in New Zealand
The food technology industry in New Zealand is rapidly evolving, driven by increasing consumer awareness regarding health, sustainability, and ethical production practices
Similar Deals
Pacific Channel → Upstream Medical Technologies
2023
Even Capital
invested in
Daisy Lab
in
in a Seed Stage deal